Open Beta
TREN
MetriLume
TREN

US marketsGWLL

SEC-sourced researchBeta

GWLL

GOLDENWELL BIOTECH, INC.

Company comparison ↗

Data passport

CIK
0001800373
Exchange
OTC
Business activity
— · SIC 2000
Financial inputs
6/6
Filing date
Sep 29, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 139.0000 USD; December 2025: 55.0000 USD139 USD0 USD0December 2024December 2025
GWLL · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024139.0000Jul 1, 2026
December 202555.0000Jul 1, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202555.0000-296,471.0000-22,629.000036,120.0000379,833.0000Jul 1, 2026
December 2024139.0000-131,498.0000-123,077.0000224,192.0000271,433.0000Jul 1, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$55December 2025Jul 1, 202610-K
Previous period revenueRevenues$139December 2024Jul 1, 202610-K
Net incomeNetIncomeLoss-$296.47KDecember 2025Jul 1, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$22.63KDecember 2025Jul 1, 202610-K
Total assetsAssets$36.12KDecember 2025Jul 1, 202610-K
Total liabilitiesLiabilities$379.83KDecember 2025Jul 1, 202610-K

New filings

Explore methodology ↗